Ruchi Agarwal

20 posts

Ruchi Agarwal

Ruchi Agarwal

@ruchi1agarwal

Undergraduate @Penn | Research @CityofHope

Philadelphia, PA Katılım Nisan 2020
36 Takip Edilen34 Takipçiler
Petros Grivas
Petros Grivas@PGrivasMDPhD·
So proud of Ruchi, I initially met her in 2013 when @neerajaiims kindly invited me & @montypal to his home! Ruchi will do amazing things in her career, stay tuned! Tremendous mentorship by brilliant Monty Pal! @OncoAlert @TiansterZhang @Uromigos @shilpaonc @UroDocAsh @spsutkaMD
Petros Grivas tweet mediaPetros Grivas tweet media
Tom Powles@tompowles1

Ruchi Agarwal #IKCSEU26 @montypal showing microbiome manipulation may enhance efficacy of ipi/nivo in clear cell renal cancer (with CBM588). Randomized phase 3 trials are underway based on this work. This well tolerated intervention is as promising as any other in RCC at present IMO. @OncoAlert @DrChoueiri

English
2
8
40
5.5K
Ruchi Agarwal retweetledi
Tom Powles
Tom Powles@tompowles1·
Ruchi Agarwal #IKCSEU26 @montypal showing microbiome manipulation may enhance efficacy of ipi/nivo in clear cell renal cancer (with CBM588). Randomized phase 3 trials are underway based on this work. This well tolerated intervention is as promising as any other in RCC at present IMO. @OncoAlert @DrChoueiri
Tom Powles tweet mediaTom Powles tweet mediaTom Powles tweet media
English
5
22
67
11.1K
Sumanta K. Pal, MD, FASCO
Sumanta K. Pal, MD, FASCO@montypal·
I have to add that @ruchi1agarwal's level of commitment to our research at @cityofhope is unprecedented. As an undergraduate at @PennCancer she's managed to balance rigorous coursework with completing research projects within our group. She's spent the past 6 months in #Edinburgh on a study abroad - and still manages to log-in to our weekly research meetings without fail, which often start well past midnight her time! I'm so grateful to the committee at #IKCSEU26 (@DrIacovelli @OudardStephane #DrMaxineTran & others) for giving her the opportunity to present. Sounds like she knocked it out of the park! Keep an eye out for her med school apps next year! @TiansterZhang @NehaVapiwala @spsutkaMD @ERPlimackMD @ZakhariaYousef @KidneyCancerDoc
Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)@TiansterZhang

#RuchiAgarwal steals the show at posters #IKCSEU26, presenting data from @montypal CBM588 trials, supporting future microbiome modulating trials like @SWOG #BIOFRONT. Congrats!! @OncoAlert @KidneyCancer

English
1
7
38
2.5K
Ruchi Agarwal retweetledi
KidneyCAN
KidneyCAN@kidneycan·
All #KCRS25 session recordings are now available in the Attendee Hub for registrants—your early access is live! Didn’t register this year? No worries. Recordings will be posted soon at kcrs.kidneycan.org. Stay tuned! #AcceleratingCures
KidneyCAN tweet mediaKidneyCAN tweet mediaKidneyCAN tweet mediaKidneyCAN tweet media
English
0
5
17
966
Ruchi Agarwal retweetledi
Sumanta K. Pal, MD, FASCO
Sumanta K. Pal, MD, FASCO@montypal·
Proud of @ruchia_upenn, a @Penn undergraduate who spent her summers working with us at @cityofhope. Today she presented her work with @ReginaBarCar @incanMX on international #kidneycancer trial availability - so impressive!
Sumanta K. Pal, MD, FASCO tweet media
Cristiane D Bergerot, PhD, FASCO@crisbergerot

Wonderful presentation by @ruchia_upenn highlighting global disparities in clinical trial availability for RCC. A crucial reminder of the inequities that persist and the urgent need for more inclusive research efforts. #KCRS25

English
1
9
54
6.2K
Ruchi Agarwal retweetledi
Cristiane D Bergerot, PhD, FASCO
Cristiane D Bergerot, PhD, FASCO@crisbergerot·
Wonderful presentation by @ruchia_upenn highlighting global disparities in clinical trial availability for RCC. A crucial reminder of the inequities that persist and the urgent need for more inclusive research efforts. #KCRS25
Cristiane D Bergerot, PhD, FASCO tweet mediaCristiane D Bergerot, PhD, FASCO tweet mediaCristiane D Bergerot, PhD, FASCO tweet mediaCristiane D Bergerot, PhD, FASCO tweet media
English
2
7
24
5.8K
Ruchi Agarwal retweetledi
Neeraj Agarwal, MD, FASCO
Neeraj Agarwal, MD, FASCO@neerajaiims·
Amazing performance by the stellar @CityofHope_GU team’s junior investigators👉Two back to back @NatureMedicine original research articles from their IIT studies. Congrats @EbrahimiHedyeh @NazliDizman & team and the mega-mentor @montypal Cc @ASCO @OncoAlert @Uromigos @kidneycan
Neeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet media
Hedyeh Ebrahimi@EbrahimiHedyeh

It's with great pleasure that I share with you our paper evaluating #cabozantinib with #nivolumab +/- #CBM588 in pts with advanced #kidneycancer, published today in @NatureMedicine! 🙏Huge thanks 1st/foremost to patients & their families. Had tons of support from the amazing @cityofhope/@TGenResearch team & guidance from my mentor @montypal. (1/7)

English
1
32
72
11.8K
Ruchi Agarwal retweetledi
Neeraj Agarwal, MD, FASCO
Neeraj Agarwal, MD, FASCO@neerajaiims·
Breaking news👉@US_FDA approves Talazoparib + Enzalutamide for mCRPC #prostatecancer with HRR mutations. Weblink👉 tinyurl.com/bdhabbkt Efficacy data, HRR mutations👇@PCFnews @OncoAlert @urotoday @huntsmancancer Gratifying to see the success of this trial we started 6 yrs ago
Neeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet media
Neeraj Agarwal, MD, FASCO@neerajaiims

We report in @TheLancet : Primary efficacy data from TALAPRO-2 Phase 3 trial in mCRPC #prostatecancer : Talazoparib + Enza improves outcomes in all subgroups vs Enza. Prospective tissue testing in 100% pts, randomization stratified by HRR status @oncoalert @urotoday @PCF_Science

English
11
93
270
178.7K

Keşfet

@PGrivasMDPhD @neerajaiims @montypal @OncoAlert @TiansterZhang @Uromigos @shilpaonc @UroDocAsh